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Clostridium botulinum type A(B) strains
Brian H Raphael*, Timothy B Shirey, Carolina Lúquez and Susan E MaslankaAbstract
Background: In the United States, most Clostridium botulinum type A strains isolated during laboratory
investigations of human botulism demonstrate the presence of an expressed type A botulinum neurotoxin (BoNT/
A) gene and an unexpressed BoNT/B gene. These strains are designated type A(B). The most common pulsed-field
gel electrophoresis (PFGE) pattern in the C. botulinum PulseNet database is composed of A(B) strains. The purpose
of this study was to evaluate the ability of genome sequencing and multi-loci variable number of tandem repeat
analysis (MLVA) to differentiate such strains.
Results: The genome sequences of type A(B) strains evaluated in this study are closely related and cluster together
compared to other available C. botulinum Group I genomes. In silico multilocus sequence typing (MLST) analysis
(7-loci) was unable to differentiate any of the type A(B) strains isolated from seven different outbreak investigations
evaluated in this study. A 15-locus MLVA scheme demonstrated an improved ability to differentiate these strains,
however, repeat unit variation among the strains was restricted to only two loci. Reference-free single nucleotide
polymorphism (SNP) analysis demonstrated the ability to differentiate strains from all of the outbreaks examined
and a non-outbreak associated strain.
Conclusions: This study confirms that type A(B) strains that share the same PFGE pattern also share closely-related
genome sequences. The lack of a complete type A(B) strain representative genome sequence hinders the ability to
assemble genomes by reference mapping and analysis of SNPs at pre-identified sites. However, compared to other
methods evaluated in this study, a reference-free SNP analysis demonstrated optimal subtyping utility for type A(B)
strains using de novo assembled genome sequences.
Keywords: Botulism, Pulsed-field gel electrophoresis, Multi-loci variable number of tandem repeat analysis,
Comparative genomic analysis, Single nucleotide polymorphismBackground
Botulism is a paralytic disease caused by the action of
botulinum neurotoxins (BoNT) at neuromuscular junc-
tions. BoNTs are produced by various botulinum toxin
producing clostridia (BTPC) including Clostridium botu-
linum and some strains of C. butyricum and C. baratii
[1]. Botulism can occur when food contaminated with
BoNT is ingested or when organisms producing BoNT
colonize the intestine (eg. infant botulism, adult intes-
tinal colonization botulism) or when these organisms
infect and produce toxin in wounds (eg. wound botulism
due to traumatic injury or injection drug use) [1].* Correspondence: BRaphael@cdc.gov
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unless otherwise stated.C. botulinum are classified into four Groups (I-IV)
which are distinguished by biochemical properties and
phylogenetic differences [2]. All strains of C. botulinum
that produce BoNT/A belong to Group I. Nucleotide
sequencing of the genes encoding BoNT/A reveals the
presence of several toxin subtypes (eg. A1-A5) which
form unique clades [3-5]. Some type A strains that pro-
duce BoNT/A also harbor an unexpressed gene encod-
ing BoNT/B and are designated type A(B) [6].
Between 2010 and 2013, 47 C. botulinum type A strains
were isolated during 36 laboratory investigations of botu-
lism at the Centers for Disease Control and Preventionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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possess an unexpressed BoNT/B gene suggesting that
type A(B) strains are common among US botulism cases
(unpublished data). The bont/A1 nucleotide sequence
associated with type A(B) strains is highly conserved
and contains only two nucleotide substitutions com-
pared to the bont/A1 sequence found in type A strains
without an unexpressed bont/B [3]. A focused micro-
array featuring selected oligonucleotide probes based on
the C. botulinum type A strain ATCC3502 genome se-
quence was unable to distinguish a group of unrelated
type A(B) strains which suggested that these strains may
share a high degree of genomic content [7]. Using a larger
DNA microarray featuring probes targeting coding
sequences in the ATCC3502 genome sequence, Carter
et al. [4] demonstrated that several type A(B) strains
isolated in North America shared a high degree of gen-
omic content. Analysis of diverse panels of C. botulinum
strains using multi-loci variable number of tandem
repeat analysis (MLVA) and amplified fragment length
polymorphism (AFLP) demonstrate that type A(B)
strains cluster separately from strains encoding other
bont/A subtypes and from strains expressing BoNT/A1
but lacking an unexpressed bont/B [3,8]. More recently, a
standardized C. botulinum pulsed-field gel electrophoresis
(PFGE) method has been established (http://www.cdc.gov/
pulsenet/PDF/c-botulinum-protocol-508c.pdf). A national
subtyping database (PulseNet) of PFGE patterns using
this method is maintained at CDC and individual pat-
terns are given unique identifiers. The most frequent
SmaI PFGE pattern (30%) observed among 256 C. botu-
linum types A, B, E, and F strains examined has been
designated DRPS16.0001. Additional characterization of
these strains revealed that they are type A(B) and all
share the same PFGE XhoI pattern (DRPX11.0001).
During laboratory investigations of botulism, specimens
from different sources may be examined. For instance, in
a foodborne botulism outbreak, clinical samples (such as
serum and stool) from one or more individuals as well as
suspected food sources may be submitted for testing.
Toxin detection either in clinical samples or food ingested
by individuals with clinical symptoms of botulism is suffi-
cient for laboratory confirmation [1]. Additionally, BTPC
may also be isolated from both stool and food. Isolation
of BTPC from stool of individuals with botulism pro-
vides ancillary evidence of toxin serotype when toxin is
also detected in clinical specimens. In some cases, isola-
tion of BTPC in stool of individuals with symptoms
of botulism provides the only evidence for laboratory
confirmation in clinical specimens. Similarly, isolation
of BTPC from foods provides supportive results for the
identification of toxin in a contaminated food. However,
isolation of BTPC only in a food source is insufficient
for laboratory confirmation due to the ubiquity of suchorganisms in the environment. In some investigations,
left over food actually consumed by patients is not avail-
able but equivalent lots may be recovered from the
home or manufacturer. Therefore, subtyping methods
that permit comparison of BTPC isolates from different
sources have an important role in supporting epidemio-
logical links among samples examined during a labora-
tory investigation of botulism especially in cases where
toxin cannot be detected directly in the sample submit-
ted for testing.
In this study, type A(B) strains isolated from different
sources among separate foodborne botulism outbreaks
occurring in the US were selected for study because they
shared indistinguishable SmaI and XhoI PFGE patterns
(Table 1). An additional type A(B) strain (CDC42961)
that was unrelated to any of the botulism outbreaks was
selected as an outlier. We examined the ability of high
resolution subtyping methods including MLVA and gen-
ome sequence analysis (e.g. fragmented genome align-
ment, in slico multilocus sequence typing (MLST)
analysis, reference-free SNP analysis) to distinguish these
type A(B) strains isolated from separate botulism out-
breaks yet sharing a common PFGE pattern. This
work confirms that these type A(B) strains are highly-
related and evaluates the utility of methods for clus-
tering C. botulinum type A(B) strains isolated from
separate sources during an outbreak investigation.Methods
Bacterial strains used in this study
C. botulinum strains used in this study are indicated in
Table 1. Strains were grown in Trypticase Peptone Yeast
Extract (TPGY; Remel, Lenexa, KS) at 35°C under
anaerobic conditions. Two representative strains from
different sources were selected from seven separate pre-
vious laboratory investigations. An additional strain
(CDC42961) unrelated to any of these investigations
was also examined.
For additional studies, some isolates associated with
outbreak #5 are further identified as “picks” based on
their original isolation from enrichment cultures of
a single sample. The pick designation following the
strain number refers to the enrichment culture from
which a single colony isolate was derived as follows:
H = heated (80°C, 15 minutes) Cooked Meat Glucose
Starch (CMGS; Remel, Lenexa, KS), T = TPGY contain-
ing 0.09% trypsin, PL = untreated (plain) CMGS. Separ-
ate single colonies from each enrichment culture type
are indicated by a digit following the pick designation.
All strains were coded prior to the study and managed
in compliance with a human subjects exemption proto-
col (#4991.0) approved by the CDC Human Research
Protection Office.
Table 1 Characteristics of strains used in this study
Outbreak Referencea Strain Source Origin Year isolated SmaI PFGE pattern XhoI PFGE pattern
1
This study
CDC28012 Stool Utah 1973 DRPS16.0001 DRPX11.0001
CDC28023 Chili Utah 1973 DRPS16.0001 DRPX11.0001
2
This study
CDC33700 Stool Florida 1988 DRPS16.0001 DRPX11.0001
CDC33702 Seafood pasta Florida 1988 DRPS16.0001 DRPX11.0001
3
This study
CDC37457 Stoolb Alaska 1982 DRPS16.0001 DRPX11.0001
CDC37461 Stoolb Alaska 1982 DRPS16.0001 DRPX11.0001
4
[18]
CDC48719 Stool Georgia 1993 DRPS16.0001 DRPX11.0001
CDC48761 Swab from cutting board Georgia 1993 DRPS16.0001 DRPX11.0001
5
[19,20]
CDC52271 Chili sauce Indiana 2007 DRPS16.0001 DRPX11.0001
CDC52298 Stool Indiana 2007 DRPS16.0001 DRPX11.0001
6
This study
CDC66088 Stool New York 2011 DRPS16.0001 DRPX11.0001
CDC66089 Cooked barley, sausage, cheese New York 2011 DRPS16.0001 DRPX11.0001
7
[21]
CDC67187 Rectal Swab Arizona 2012 DRPS16.0001 DRPX11.0001
CDC67190 Pruno Arizona 2012 DRPS16.0001 DRPX11.0001
NAc This study CDC42961 Unknownd Ecuador 1997 DRPS16.0001 DRPX11.0001
aWhere available, references shown describe a specific outbreak or investigation.
bStool samples isolated from different individuals with foodborne botulism associated with “stink eggs”.
cNA = not applicable; strain CDC42961 is not epidemiologically associated with any other strain examined in this study.
dStrain received at CDC as a culture.
Raphael et al. BMC Microbiology 2014, 14:192 Page 3 of 8
http://www.biomedcentral.com/1471-2180/14/192MLVA
MLVA was performed using the 15-loci scheme de-
scribed by Fillo et al. [9]. Fragment analysis was per-
formed as a separate reaction for each allele using a
CEQ8000 Genetic Analysis System and the Genome-
Lab™ DNA Size Standard Kit – 600 (Beckman Coulter,
Brea, CA). The largest peaks were identified in the frag-
ment analysis and repeat units (RU) are expressed as
the lowest number of intact units.
Genome sequencing
Genomic DNA was extracted from overnight TPGY
cultures as described previously [10] and further puri-
fied using the DNA Clean & Concentrator-5 kit (Zymo
Research, Irvine, CA). Fragment libraries were con-
structed using 100 ng of genomic DNA with the Ion
Xpress™ Fragment Library kit and size-selection was
performed using the E-Gel® Agarose Gel Electrophor-
esis System (Life Technologies, Grand Island, NY).
Library concentrations were determined using the
Qubit® dsDNA HS Assay (Life Technologies, Grand
Island, NY) and diluted to a final concentration of 18
pM. Templates were generated using the Ion One-
Touch™ 200 Template Kit v2 and sequencing was per-
formed using the Ion Torrent™ Personal Genome
Machine (PGM™) with 314 v2 chips. Barcoded fragment
libraries of various “picks” of strains CDC 52271 and CDC
52298 were generated with the Ion Torrent-compatible
Bioo Scientific (Austin, TX) NEXflex™ DNA barcodes
and sequenced with a 316 v2 chip.Bioinformatic analysis
Sequence reads were de novo assembled using MIRA
v3.9.9 (performed with the Assembler plug-in on the
Torrent Suite 4.0.2 software). Assembled genome
metrics and GenBank accession numbers are shown
in Table 2. Draft genomes were compared using
Gegenees software which aligns fragments of each se-
quence using BLAST and generates a phylogenomic
distance based on the average similarity score of frag-
ments in pairwise alignments [11]. In silico MLST
was performed using the MLST 1.7 tool available at
Center for Genomic Epidemiology website (http://
cge.cbs.dtu.dk/services/MLST/) [12]. Single nucleotide
polymorphism (SNP) discovery was performed on
concatenated sequence data using the SNP detection
program kSNP v1 [13] with a k-mer size of 21. Max-
imum parsimony trees were constructed in MEGA
v5.2 [14] using core SNP data matrices, which in-
clude only SNPs detected at loci that were present in
all genomes.
Results and discussion
Resolution of C. botulinum type A(B) strains using MLVA
Only 2 of the 15 loci (i.e. loci 1 and 4 reported by Filio
et al. [9]) examined using MLVA displayed variation
in RU among the strains examined in this study
(Table 3). Outbreak-related strains shared identical
MLVA profiles with the exception of strains compos-
ing outbreak #3 and outbreak #5 which had a divergent
number of repeats at various loci. In addition, the strains
Table 2 Draft genome sequence properties
Strain # reads assembled Genome size (Mb) # contigs N50 (kb) Coverage (X) GenBank accession number
CDC28012 547,889 3.97 400 19.1 29 JFGN01000000
CDC28023 522,829 3.97 341 22.3 27 JFGM01000000
CDC33700 556,551 3.68 869 6.4 30 JFGL01000000
CDC33702 638,235 3.70 880 6.2 37 JFGK01000000
CDC37457 594,516 3.90 456 14.5 34 JFGJ01000000
CDC37461 502,932 3.90 389 18.4 29 JFGI01000000
CDC48719 625,316 3.98 310 26.1 29 JFGH01000000
CDC48761 646,981 3.96 418 17.0 36 JFGG01000000
CDC52271 519,456 3.89 399 16.9 28 JFGF01000000
CDC52298 502,934 3.87 524 12.0 28 JFGE01000000
CDC66088 801,959 3.83 1,086 5.6 42 JFGD01000000
CDC66089 458,975 3.44 1,093 4.1 26 JFGC01000000
CDC67187 462,117 3.56 1,079 4.4 27 JFGB01000000
CDC67190 594,808 3.73 1,046 5.0 35 JFGA01000000
CDC42961 681,808 3.89 684 9.4 35 JFFZ01000000
Raphael et al. BMC Microbiology 2014, 14:192 Page 4 of 8
http://www.biomedcentral.com/1471-2180/14/192composing some outbreaks could not be resolved
from those isolated from separate outbreaks. More
specifically, the strains associated with outbreaks #6
and #7 shared identical MLVA profiles. Moreover,
strains composing outbreak #2 and the outlying strain
CDC42961 shared the same MLVA profile. Taken
together, these results demonstrate that MLVA only
partially differentiates closely related type A(B) strainsTable 3 MLVA results
Number of repeat units (RU)
Locus 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
CDC28012 9 –a 5 8 12 2 4 6 2 13 3 1 23 6 3
CDC28023 9 – 5 8 12 2 4 6 2 13 3 1 23 6 3
CDC33700 8 – 5 7 12 2 4 6 2 13 3 1 23 6 3
CDC33702 8 – 5 7 12 2 4 6 2 13 3 1 23 6 3
CDC37457 7 – 5 8 12 2 4 6 2 13 3 1 23 6 3
CDC37461 8 – 5 7 12 2 4 6 2 13 3 1 23 6 3
CDC48719 8 – 5 9 12 2 4 6 2 13 3 1 23 6 3
CDC48761 8 – 5 9 12 2 4 6 2 13 3 1 23 6 3
CDC52271 7 – 5 7 12 2 4 6 2 13 3 1 23 6 3
CDC52298 11 – 5 7 12 2 4 6 2 13 3 1 23 6 3
CDC66088 8 – 5 8 12 2 4 6 2 13 3 1 23 6 3
CDC66089 8 – 5 8 12 2 4 6 2 13 3 1 23 6 3
CDC67187 8 – 5 8 12 2 4 6 2 13 3 1 23 6 3
CDC67190 8 – 5 8 12 2 4 6 2 13 3 1 23 6 3
CDC42961 8 – 5 7 12 2 4 6 2 13 3 1 23 6 3
aDeletions are indicated by a “–“symboland not all strains associated with separate outbreaks
could be resolved.
Genome sequencing reveals that C. botulinum type A(B)
strains are highly-related
Draft genome sequences from the 15 type A(B) strains
were compared along with several reference genomes
selected from the National Center for Biotechnology
Information (NCBI) database using a fragmented align-
ment (Figure 1). This comparison showed that all of the
type A(B) genomes (including a separately sequenced
type A(B) strain NCTC2916) were closely related and
formed a unique clade. Within this clade, only one pair of
outbreak-associated strains (CDC33700 and CDC33702)
branched from a shared node indicating that such analysis
is unsuitable for clustering outbreak-related strains that
share a high degree of genomic similarity.
As shown in Table 4, in silico MLST analysis dem-
onstrated that all 15 draft genome sequences matched
identically (or nearly identically) with the alleles
forming ST-4 in the MLST scheme reported by Jacobson
et al. [15]. In some cases, nucleotide mismatches with
the best-matched allele occurred (usually in homopol-
ymer regions) or the draft sequence did not cover the
entire best-matched allele (for instance when the
allele sequence was truncated by the end of a conti-
guous sequence). Several type A(B) strains are associ-
ated with ST-4 including the reference genome
sequence of strain NCTC2916 (Table 4) and 13 out of
24 type A(B) strains examined by Jacobson et al. [15].
In that study, ST-4 was composed exclusively of type
A(B) strains.
A(B)
Figure 1 Phylogenomic analysis of C. botulinum Group I strains. C. botulinum Group I genome sequences were compared using a fragmented
alignment and a neighbor joining tree of phylogenomic distances is shown. The cluster of type A(B) strains is indicated. The accession numbers of
sequences obtained from the NCBI genomes database are as follows: GenBank:NC_017297 (230613 F), GenBank:NC_009699 (Langeland), GenBank:
NC_010516 (Okra), GenBank:NC_012658 (657), GenBank:NZ_ABDP00000000 (Bf), GenBank:NZ_AOSX00000000 (Af84), GenBank:NC_012563 (Kyoto),
GenBank:NZ_ABDO00000000 (NCTC2916), GenBank:NC_009697 (ATCC19397), GenBank:NC_009698 (Hall), GenBank:NC_009495 (ATCC3502), GenBank:
NC_017299 (H04402065), GenBank:NC_010520 (LochMaree), GenBank:AZQW01000000 (CDC54075); GenBank:AZRQ01000000 (CDC54085); GenBank:
AZRR01000000 (CDC54091); and GenBank:AZRS01000000 (CDC54088).
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reference-free SNP analysis
Previous work has demonstrated the utility of reference-
free SNP analysis for the differentiation of C. botulinum
Group I strains including those with identical BoNT
subtypes [16]. This work was performed using thesoftware program, kSNP, which can be used to identify
SNPs among a set of draft and/or complete microbial
genomes without the need for comparison to a refer-
ence genome [13,17]. Analysis of the 15 draft genomes
generated in this study using kSNP revealed the pres-
ence of 145 core SNPs (i.e. SNPs detected at loci
Table 4 In silico MLST best match results
% Identity/% Coverage of allele
Locusa aceK aroE hsp mdh oppB recA rpoB
Allele 6 9 8 10 9 7 8
CDC28012 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC28023 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC33700 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC33702 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC37457 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC37461 100/100 100/100 100/90.4 100/100 100/100 100/100 100/100
CDC42961 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC48719 100/100 99.8/100 100/100 100/100 100/100 100/100 100/100
CDC48761 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC52271 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC52298 100/100 100/100 100/100 100/100 100/100 100/100 100/100
CDC66088 100/100 100/100 100/100 100/96.0 100/100 100/100 100/100
CDC66089 100/100 100/100 100/100 100/100 99.6/100 100/100 100/100
CDC67187 100/100 99.8/100 100/93.4 100/100 100/100 100/100 100/100
CDC67190 100/100 100/100 100/100 100/100 100/100 100/100 100/100
NCTC2916 100/100 100/100 100/100 100/100 100/100 100/100 100/100
aLoci refer to those genes used in the MLST scheme developed by Jacobson et al. [15].
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SNPs demonstrated that strains associated with each
outbreak generally clustered together (Figure 2) and
differed by only 3–8 SNPs. However, the strains associ-
ated with outbreak #5 (CDC52271 and CDC52298)Figure 2 SNP analysis of C. botulinum type A(B) draft genomes seque
parsimony tree of the core SNP matrix is shown. Outbreak-related strains awere more divergent and differed by 56 SNPs. Notably,
strain CDC42961, which is not associated with any of
the seven outbreaks examined, did not cluster with any
other strain suggesting that this approach may success-






nces. Core SNPs were identified using kSNP and a maximum
re indicated by outbreak number as shown in Table 1.
12
Figure 3 SNP analysis of strains isolated from outbreak #5. Core SNPs were identified using kSNP and a maximum parsimony tree of the
core SNP matrix is shown. The sequences cluster into two groups as indicated in the figure.
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In order to better assess the genetic diversity of the
strains isolated from outbreak #5, several “picks” derived
from single colonies originally isolated from different
enrichment cultures of each sample (i.e. stool and food
samples) were examined. Genome sequencing of these
isolates revealed the presence of two groups (Figure 3).
Group 1 contained the originally examined genome se-
quence of strain CDC52298 and two picks (CDC52298
PL-1 and CDC52298 T-1) from the same source (stool).
Also included in Group 1 were picks (CDC52271 B-2,
CDC52271 H-1) associated with the implicated food
(chili sauce). Group 2 only contained the original strain
CDC52271 genome sequence and one pick (CDC52271
B-1) associated with the same source. The number of
SNPs differentiating strains associated with Groups 1
and 2 ranged from 56–63. The sequences of strains
within Group 1 differed by only 4–10 SNPs and those
composing Group 2 differed by only 3 SNPs. Notably,
the MLVA profiles of CDC52298 PL-1, CDC52298 T-1,
CDC52271 H-1, and CDC52271 B-2 were identical and
also different than the profile of 52271 B-1 (data not
shown), thus supporting the clustering of these isolates
by SNP analysis. These data indicate that the contami-
nated food product contained at least two separate pop-
ulations of type A(B) strains and that the strains
isolated from stool of an individual who consumed the
food were associated with only one these populations.
These populations differ by multiple mutational events
and are unlikely to be the result of recent divergence.
However, more detailed comparative genomic analysis
of these strains is hindered by the lack of a complete
reference genome sequence.
Conclusions
The C. botulinum type A(B) strains examined in this
study which shared indistinguishable PFGE profiles
also shared a high degree of genomic sequence similar-
ity. While the type A(B) strains clustered together in acomparison of C. botulinum Group I genome sequences
using a fragmented alignment, this method did not
resolve strains associated with separate outbreaks. The
lack of adequate resolution using this method may have
been influenced by differences in the overall level of
genome coverage among the de novo assembled ge-
nomes, which share little sequence variation. Strains
isolated from separate foodborne botulism outbreaks
also could not be distinguished by in silico MLST and
only partially by MLVA.
These results suggested that genetic differences among
this group of highly-related type A(B) strains may be
restricted to a limited number of SNPs. A complete C.
botulinum type A(B) genome sequence is not currently
available thereby preventing the ability to perform refer-
ence alignments of sequencing reads and assessment of
variation at specific SNP loci. However, reference-free
SNP analysis of de novo aligned draft sequences effectively
resolved strains isolated from 7 separate outbreaks and an
outlying unassociated type A(B) strain. It is important to
note that strains isolated from the same outbreak shared a
low number of SNPs. It is unclear if these SNPs are asso-
ciated with actual genetic variation or are artifacts of
sequencing errors. Future work identifying high quality
SNPs based on comparison with one or more reference
genome sequences of such strains is needed.
In addition, this study demonstrates that a contaminated
food product may contain multiple strains of C. botulinum
some of which could be genetically distinguishable from
clinical sample isolates. This finding suggests that subtyp-
ing methods may need to be applied to several isolates
from the same source to ensure adequate sampling of
multiple strain populations that may be present.
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